References
[1] D.M. Bennion, U.M. Steckelings, C. Sumners. Neuroprotection via AT2 receptor agonists in ischemic stroke. Clin Sci (Lond), 132(10), (2018), 1055-1067.
[2] Y.C. Tang, H.X. Tian, T. Yi, H.B. Chen. The critical roles of mitophagy in cerebral ischemia. Protein Cell, 7(10), (2016), 699-713.
[3] D. Mozaffarian, E.J. Benjamin, A.S. Go, D.K. Arnett, M.J. Blaha, M. Cushman, S. de Ferranti, J.P. Despres, H.J. Fullerton, V.J. Howard, M.D. Huffman, S.E. Judd, B.M. Kissela, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, S.M. Liu, R.H. Mackey, D.B. Matchar, D.K. McGuire, E.R. Mohler, C.S. Moy, P. Muntner, M.E. Mussolino, K. Nasir, R.W. Neumar, G. Nichol, L. Palaniappan, D.K. Pandey, M.J. Reeves, C.J. Rodriguez, P.D. Sorlie, J. Stein, A. Towfighi, T.N. Turan, S.S. Virani, J.Z. Willey, D. Woo, R.W. Yeh, M.B. Turner, A.H.A.S. Comm, S.S. Subcomm. Heart disease and stroke statistics-2015 update A report from the American heart association. Circulation, 131(4), (2015), E29-E322.
[4] Y.F. Wang, S.E. Tsirka, S. Strickland, P.E. Stieg, S.G. Soriano, S.A. Lipton. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice (vol 4, pg 228, 1998), Nat. Med., 4(5), (1998), 633-633.
[5] N. Henninger, M. Fisher. Extending the time window for endovascular and pharmacological reperfusion. Translational stroke research, 7(4), (2016), 284-293.
[6] A. Tuttolomondo, R. Di Sciacca, D. Di Raimondo, V. Arnao, C. Renda, A. Pinto, G. Licata. Neuron protection as a therapeutic target in acute ischemic stroke. Curr. Top. Med. Chem., 9 (14), (2009), 1317-1334.
[7] M.D. Ginsberg. Expanding the concept of neuroprotection for acute ischemic stroke: the pivotal roles of reperfusion and the collateral circulation. Prog. Neurobiol., 145(2016), 46-77.
[8] K. Wei, P. Wang, C. Miao. A double-edged sword with therapeutic potential: an updated role of autophagy in ischemic cerebral injury. CNS Neurosci. Ther., 18 (11), (2012), 879-886.
[9] S. Pickles, P. Vigie, R.J. Youle. Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr. Biol., 28(4), (2018), R170-R185.
[10] S.H. Baek, A.R. Noh, K.A. Kim, M. Akram, Y.J. Shin, E.S. Kim, S.W. Yu, A. Majid, O.N. Bae. Modulation of mitochondrial function and autophagy mediates carnosine neuroprotection against ischemic brain damage. Stroke, 45 (8), (2014), 2438-2443.
[11] R. Guan, W. Zou, X. Dai, X. Yu, H. Liu, Q. Chen, W. Teng. Mitophagy, a potential therapeutic target for stroke. J. Biomed. Sci., 25 (1), (2018), 87.
[12] K. Liu, Y. Sun, Z. Gu, N. Shi, T. Zhang, X. Sun. Mitophagy in ischaemia/reperfusion induced cerebral injury. Neurochem. Res., 38 (7), (2013), 1295-1300.
[13] X.M. Zhang, L. Zhang, G. Wang, W. Niu, Z. He, L. Ding, J. Jia. Suppression of mitochondrial fission in experimental cerebral ischemia: the potential neuroprotective target of p38 MAPK inhibition. Neurochem. Int., 90, (2015), 1-8.
[14] J.H. Feng, X.M. Chen, J.G. Shen. Reactive nitrogen species as therapeutic targets for autophagy: implication for ischemic stroke. Expert Opin. Ther. Targets, 21 (3), (2017), 305-317.
[15] J. Feng, X. Chen, B. Guan, C. Li, J. Qiu, J. Shen. Inhibition of peroxynitrite-induced mitophagy activation attenuates cerebral ischemia-reperfusion injury. Mol.Neurobiol., 55 (8), (2018), 6369-6386.
[16] W. Zuo, P.F. Yang, J. Chen, Z. Zhang, N.H. Chen. Drp-1, a potential therapeutic target for brain ischaemic stroke. Br. J. Phar-macol., 173 (10), (2016), 1665-1677.
[17] W. Zuo, S. Zhang, C.Y. Xia, X.F. Guo, W.B. He, N.H. Chen. Mitochondria autophagy is induced after hypoxic/ischemic stress in a Drp1 dependent manner: the role of inhibition of Drp1 in ischemic brain damage. Neuropharmacology, 86 (2014), 103-115.
[18] L. Buhlman, M. Damiano, G. Bertolin, R. Ferrando-Miguel, A. Lombès, A. Brice, O. Corti. Functional interplay between Parkin and Drp1 in mitochondrial fission and clearance. Biochim. Biophys. Acta., 1843 (9), (2014), 2012-2026.
[19] S. Kawajiri, S. Saiki, S. Sato, F. Sato, T. Hatano, H. Eguchi, N. Hattori. PINK1 is recruited to mitochondria with parkin and associates with LC3 in mitophagy. FEBS Lett., 584 (6), (2010), 1073-1079.
[20] Q. Wu, C.L. Luo, L.Y. Tao. Dynamin-related protein 1 (Drp1) mediating mitophagy contributes to the pathophysiology of nervous system diseases and brain injury. Histol. Histopathol, 32 (6), (2017), 551-559.
[21] R. Lan, J.T. Wu, T. Wu, Y.Z. Ma, B.Q. Wang, H.Z. Zheng, Y.N. Li, Y. Wang, C.Q. Gu, Y. Zhang. Mitophagy is activated in brain damage induced by cerebral ischemia and reperfusion via the PINK1/Parkin/p62 signalling pathway. Brain Res. Bull., 142(2018), 63-77.
[22] M. Dole, F. R. Wilson, and W. P. Fife. Hyperbaric hydrogen therapy: a possible treatment for cancer. Science, vol. 190, no. 4210, pp. 152-154, 1975.
[23] J. Y. Zhang, C. Liu, L. Zhou, et al. A review of hydrogen as a new medical therapy. Hepato-Gastroenterology, vol. 59, no. 116, pp. 1026-1032, 2012.
[24] Y. Terasaki, I. Ohsawa, M. Terasaki, et al. Hydrogen therapy attenuates irradiation-induced lung damage by reducing oxidative stress. American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 301, no. 4, pp. L415-L426, 2011.
[25] Y. Yang, Y. Zhu, and X. Xi. Anti-inflammatory and antitumor action of hydrogen via reactive oxygen species. Oncology Letters, vol. 16, no. 3, pp. 2771-2776, 2018.
[26] Y. Fu, M. Ito, Y. Fujita, et al. Molecular hydrogen is protective against 6-hydroxydopamine -induced nigrostriatal degeneration in a rat model of Parkinson's disease. Neuroscience Letters, vol. 453, no. 2, pp. 81-85, 2009.
[27] B. J. Dixon, J. Tang, and J. H. Zhang. The evolution of molecular hydrogen: a noteworthy potential therapy with clinical significance. Medical Gas Research, vol. 3, no. 1, pp. 10-12, 2013.
[28] Wei Ran, Lin Gaoxiang, Ma Feifei, et al. Effect of hydrogen on apoptosis and related protein expression in myocardial ische-mia/reperfusion injury in diabetic rats. Chongqing Medical, 2014, 43 (23): 3031-3036.
[29] Lin Gaoxiang, Song Xinnan, Yue Qiang, Hu Rong. Effect of notoginseng total saponins on TNF-αin CPB-induced rat brain injury [J]. Huaxia Medicine, 2015, 28(06):1-4.
[30] Wei Ran, Lin Gaoxiang, Ma Feifei, Tan Yongxing. Effect of hydrogen on apoptosis and associated protein expression in myocardial ischemia/reperfusion injury in diabetic rats [J]. Chongqing Medicine, 2014, 43(23):30301-3036.